In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
Previous Story
Could the Union Victory at VW Set Off a Wave?
Next Story
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
